Inertial−Digital Microfluidics Platform for High-Recovery, High-Purity Circulating Tumor Cell Isolation toward Single-Cell Genomic Analysis
Analytical Chemistry · 03.11.2026
DOI: 10.1021/acs.analchem.6c05614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 03.11.2026. Verfasst von Jiao Zhai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, and Tung Biomedical Sciences Centre, City University of Hong Kong, 83 Tat Chee Avenue, Kowloon, Hong Kong SAR99907…. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Single-Cell Analysis, Cell Separation, Microfluidic Analytical Techniques. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Innovation and Technology Fund, Hebei University of Technology, Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone Shenzhen Park Project.
Abstract (Originalsprache)
Isolating circulating tumor cells (CTCs) remains challenging owing to their rarity and the abundant background of white blood cells (WBCs). To overcome the traditional trade-off between the recovery rate and purity, we developed an orthogonal decoupling microfluidic platform consisting of two integrated modules. The integrated modules achieved an overall recovery of ∼87.3% and an overall WBCs depletion of 99.97%, reducing background WBCs contamination to a level that permitted direct microscopic visualization and single-cell isolation. Specifically, the first spiral inertial microfluidic module achieved an approximately 90% recovery rate for MCF-7 and HeLa cells (at a flow speed of 3 mL/min) while depleting 99.4% of WBCs. Second, a downstream digital microfluidic module removed >95% of residual WBCs using immunomagnetic depletion and isolated single MCF-7 cells via electrowetting-on-dielectric actuation combined with hydrophilic microstructures. Subsequent whole-genome sequencing of single MCF-7 cells from spiked samples successfully detected expected copy number variations (1q/8q amplifications) and a PIK3CA mutation, confirming the integrated platform’s reliability. In preliminary clinical testing of blood samples obtained from patients with cancer, the platform successfully identified and isolated EpCAM/PanCK-positive and CD45-negative CTCs. Overall, this integrated approach resolves the CTC recovery−purity bottleneck, enabling precision single-cell genomics from spiked samples and providing a robust foundation for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, and Tung Biomedical Sciences Centre, City University of Hong Kong, 83 Tat Chee Avenue, Kowloon, Hong Kong SAR999077, P. R. China.
- Key Laboratory of Hebei Province for Molecular Biophysics, Institute of Biophysics, School of Health Sciences & Biomedical Engineering, Hebei University of Technology, Tianjin300130, China.
- Department of Precision Diagnostic and Therapeutic Technology, City University of Hong Kong Futian Research Institute, Shenzhen, Guangdong518000, P. R. China.
ORCID-Profile: Jiao Zhai, Mengsu Yang
Förderung
- Innovation and Technology Fund
- Hebei University of Technology
- Hetao Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone Shenzhen Park Project
- City University of Hong Kong
Zitieren
APA
Zhai, J., Si, T., Wu, W., Zhang, Y., & Yang, M. (2026). Inertial−Digital Microfluidics Platform for High-Recovery, High-Purity Circulating Tumor Cell Isolation toward Single-Cell Genomic Analysis. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c05614
Vancouver
Zhai J, Si T, Wu W, Zhang Y, Yang M. Inertial−Digital Microfluidics Platform for High-Recovery, High-Purity Circulating Tumor Cell Isolation toward Single-Cell Genomic Analysis. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c05614
BibTeX
@article{Zhai2026,
author = {Zhai, Jiao and Si, Tongxu and Wu, Wanqing and Zhang, Ying and Yang, Mengsu},
title = {Inertial−Digital Microfluidics Platform for High-Recovery, High-Purity Circulating Tumor Cell Isolation toward Single-Cell Genomic Analysis},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.6c05614}
}
EUVIMED